Chronoscale Holdings Corp current report, 10 January 2024

Business Context and Reporting Period

This Form 8-K is a current report filed by Ekso Bionics Holdings, Inc. (not Chronoscale Holdings Corp) on January 10, 2024, regarding a registered direct offering of common stock. The company is incorporated in Nevada and trades on the Nasdaq Capital Market under the symbol EKSO.

Key Financial Metrics and Transaction Details

  • Shares Issued: 2,967,742 shares of common stock.
  • Offering Price: $1.55 per share.
  • Gross Proceeds: Approximately $4.6 million (calculated as 2,967,742 shares x $1.55).
  • Net Proceeds: Approximately $4.0 million after deducting placement agent fees and expenses.
  • Placement Agent Fees: 7% of aggregate gross proceeds plus $60,000 in legal expenses and $10,000 in non-accountable expenses.
  • Use of Proceeds: General corporate purposes, including R&D, SG&A, strategic initiatives, and working capital.

Material Changes and Adjustments

The filing details a material adjustment to existing equity instruments due to the offering price:

  • Warrant Adjustment: The exercise price of outstanding May 2019 Warrants (covering 193,060 shares) was reduced from $3.52 to $1.55 per share pursuant to a price-based anti-dilution provision triggered by the offering.

Outlook, Risks, and Management Commentary

Management intends to utilize the net proceeds to support ongoing operations and strategic growth. The offering closed on or about January 16, 2024, subject to customary closing conditions. The filing notes that the Purchase Agreement contains customary representations, warranties, and indemnification obligations, with the full text available as Exhibit 99.1.

Key Facts for Investor Verification

  • Verify the final closing date and actual net proceeds received, as the filing states the closing was "on or about January 16, 2024."
  • Confirm the total number of outstanding shares post-offering to assess dilution impact.
  • Review the full text of the Securities Purchase Agreement (Exhibit 99.1) for specific covenants and termination provisions.
  • Monitor the company's cash burn rate relative to the $4.0 million in new liquidity to gauge runway extension.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.